- Home
- CNSP vs CISS Comparison
CNSP vs CISS Comparison
Compare CNSP & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- CISS
- Stock Information
- Founded
- CNSP 2017
- CISS 2022
- Country
- CNSP United States
- CISS Greece
- Employees
- CNSP N/A
- CISS N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- CISS Marine Transportation
- Sector
- CNSP Health Care
- CISS Consumer Discretionary
- Exchange
- CNSP Nasdaq
- CISS Nasdaq
- Market Cap
- CNSP 4.0M
- CISS 4.4M
- IPO Year
- CNSP 2019
- CISS N/A
- Fundamental
- Price
- CNSP $7.20
- CISS $1.66
- Analyst Decision
- CNSP Strong Buy
- CISS
- Analyst Count
- CNSP 1
- CISS 0
- Target Price
- CNSP $20.00
- CISS N/A
- AVG Volume (30 Days)
- CNSP 13.8K
- CISS 73.6K
- Earning Date
- CNSP 11-17-2025
- CISS 11-18-2025
- Dividend Yield
- CNSP N/A
- CISS N/A
- EPS Growth
- CNSP N/A
- CISS N/A
- EPS
- CNSP N/A
- CISS N/A
- Revenue
- CNSP N/A
- CISS $33,613,149.00
- Revenue This Year
- CNSP N/A
- CISS N/A
- Revenue Next Year
- CNSP N/A
- CISS N/A
- P/E Ratio
- CNSP N/A
- CISS $4.25
- Revenue Growth
- CNSP N/A
- CISS N/A
- 52 Week Low
- CNSP $4.93
- CISS $1.46
- 52 Week High
- CNSP $114.00
- CISS $13.38
- Technical
- Relative Strength Index (RSI)
- CNSP 46.98
- CISS 41.28
- Support Level
- CNSP $6.30
- CISS $1.46
- Resistance Level
- CNSP $7.07
- CISS $1.81
- Average True Range (ATR)
- CNSP 0.59
- CISS 0.15
- MACD
- CNSP 0.06
- CISS 0.00
- Stochastic Oscillator
- CNSP 34.80
- CISS 41.73
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.